Latest Drug Approvals news
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children
posted March 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
posted February 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Tablet Form of Evrysdi for Spinal Muscular Atrophy
posted February 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Chronic Migraines More Common in Women With Enlarged Breast Tissue
Myeloma Risk Modestly Increased in Adults With Incidentally Detected Vertebral Fracture
Spinal Cord Stimulation Cuts Pain, Improves Sensation With Diabetic Nerve Damage
Bimekizumab Well Tolerated, Efficacious Over Three Years in Axial Spondyloarthritis
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research
Approved-Label Populations for New Drugs Broader Than Trial Populations